Overview
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2025-01-01. Active
31 1140 1049 0000 7461 9300 1004
58 1050 1214 1000 0090 3126 3701- 15 1140 1049 0000 7461 9300 1001
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
In the case of a one-person management board, declarations of will on behalf of the company are made by the member of the management board. In the case of a management board consisting of two or more persons, the joint action of two members of the management board or of one member of the management board jointly with a commercial proxy is required to make declarations of will on behalf of the company.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 2,400 | $32,414.91 | 16.6667% | |
| 2,400 | $32,414.91 | 16.6667% | |
| 2,400 | $32,414.91 | 16.6667% | |
| 2,400 | $32,414.91 | 16.6667% | |
| 2,400 | $32,414.91 | 16.6667% | |
| 2,400 | $32,414.91 | 16.6667% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Kamil Okólski (32)  | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). | |
Grzegorz Piechota (50) | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Natur DayS.A. | $680,635.59 | naturday.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| F1 PharmaS.A. | $272,113.66 | f1pharma.pl | ||
| Nature's Voicesp. z o.o. | $181,977.76 | naturesvoice.eu | ||
| Ti-Comsp. z o.o. | $157,549.77 | ticomglobal.com | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| LideoS.A. | $95,067.91 | lideo.tech | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com | ||
| Grupa FinepharmS.A. | — | finepharm.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-04-04 | Share capital change (17,000.00 PLN → 720,000.00 PLN) | |
| 2025-04-04 | Name change (Bielfarm → Biocanto Pharma) | |
| 2025-04-04 | PKD change (Removed: 46.18, 47.73, 47.73.Z, 47.74, 47.75, 47.79, 47.91, 70.22, 73.1; Added: 10.89, 20.42.Z, 21.10.Z, 21.20.Z, 46.18.Z, 46.19.Z, 46.38.Z, 46.46.Z, 70.20.Z) | |
| 2024-12-16 | Address change (Al. Niepodległości 106, 43-106, Tychy → Białobrzeska 45, 41-409, Mysłowice) | |
| 2023-09-28 | Share capital change (5,000.00 PLN → 17,000.00 PLN) |
FAQ
Last updated: 2026-06-19